Publicaciones en colaboración con investigadores/as de Queen's University Belfast (42)

2024

  1. A multidisciplinary team and patient perspective on omission of surgery after neoadjuvant systemic therapy for early breast cancer: A European Society of Surgical Oncology (ESSO) Research Academy survey

    European Journal of Surgical Oncology, Vol. 50, Núm. 10

  2. Caregiver Experience Survey of Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration

    Ophthalmic Research, pp. 516-527

  3. Patient Experience Survey of Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema

    Ophthalmic research, Vol. 67, Núm. 1, pp. 311-321

  4. Patología y diagnóstico I: Comunicaciones Orales 14

    ParaJournal: Revista de la Sociedad Española de Parasitología, Núm. 5, pp. 171-178

  5. Progress in the Treatment of Alzheimer’s Disease Is Needed – Position Statement of European Alzheimer’s Disease Consortium (EADC) Investigators

    Journal of Prevention of Alzheimer's Disease

  6. Stroke in critically ill patients with respiratory failure due to COVID-19: Disparities between low-middle and high-income countries

    Heart and Lung, Vol. 68, pp. 131-144

  7. “Phylogenomic insights into brucellaceae: The Pseudochrobactrum algeriensis case”

    Infection, Genetics and Evolution, Vol. 123

2023

  1. 3D printing of microencapsulated Lactobacillus rhamnosus for oral delivery

    International Journal of Pharmaceutics, Vol. 641

  2. Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY (Leukemia, (2023), 37, 2, (339-347), 10.1038/s41375-022-01802-y)

    Leukemia

  3. Corrigendum to “Development of intranasal implantable devices for schizophrenia treatment” [Int. J. Pharm. 624 (2021) 122061] (International Journal of Pharmaceutics (2022) 624, (S0378517322006159), (10.1016/j.ijpharm.2022.122061))

    International Journal of Pharmaceutics

  4. Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY

    Leukemia, Vol. 37, Núm. 2, pp. 339-347

  5. Radiolabeled Risperidone microSPECT/CT Imaging for Intranasal Implant Studies Development

    Pharmaceutics, Vol. 15, Núm. 3

2022

  1. Development of intranasal implantable devices for schizophrenia treatment

    International Journal of Pharmaceutics, Vol. 624

  2. Drivers of and Barriers to Adherence to Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema Treatment Management Plans: A Multi-National Qualitative Study

    Patient Preference and Adherence, Vol. 16, pp. 587-604

  3. Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis

    Critical Care, Vol. 26, Núm. 1

  4. Immune Response after Skin Delivery of a Recombinant Heat-Labile Enterotoxin B Subunit of Enterotoxigenic Escherichia coli in Mice

    Pharmaceutics, Vol. 14, Núm. 2

  5. Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery

    BJS Open, Vol. 6, Núm. 1

2021

  1. Erratum: Gaia Early Data Release 3: Summary of the contents and survey properties (Astronomy and Astrophysics DOI: 10.1051/0004-6361/202039657)

    Astronomy and Astrophysics

  2. Gaia Early Data Release 3: Acceleration of the Solar System from Gaia astrometry

    Astronomy and Astrophysics, Vol. 649

  3. Gaia Early Data Release 3: Structure and properties of the Magellanic Clouds

    Astronomy and Astrophysics, Vol. 649